Application of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: Data from a Czech tertiary centre

Rheumatology (United Kingdom)

Volumn 55, Issue 1, 2016, Pages 109-114

  Soukup, Tomas ^a   Pudil, Radek ^a   Kubinova, Katerina ^a   Hromadkova, Lucie ^b   Dusek, Jaroslav ^a   Tosovsky, Marian ^a   Bradna, Petr ^a   Hrncir, Zbynek ^a   Bures, Jan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Cardiovascular; Clinical trials and methods; Epidemiology; Respiratory; Scleroderma and related disorders

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; CROSS-SECTIONAL STUDY; CZECH REPUBLIC; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART RIGHT ATRIUM; HEART RIGHT VENTRICLE VOLUME; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RELIABILITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SYSTEMIC SCLEROSIS; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84960088377     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kev327     Document Type: Article

References (16)

1. Mukerjee D, St George D, Coleiro B et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003;62:1088-93.
2. Hachulla E, Gressin V, Guillevin L et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005;52:3792-800.
3. Lefèvre G, Dauchet L, Hachulla E et al. Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and metaanalysis. Arthritis Rheum 2013;65:2412-23.
4. Galiè N, Rubin L, Hoeper M et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet 2008;371:2093-100.
5. Humbert M, Yaici A, de Groote P et al. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum 2011;63: 3522-30.
6. Coghlan JG, Denton CP, Grünig E et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis 2014;73:1340-9.
7. Galiè N, Hoeper MM, Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30: 2493-537.
8. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
9. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
10. Lang RM, Bierig M, Devereux RB et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
11. Jurcut R, Giusca S, La Gerche A et al. The echocardiographic assessment of the right ventricle: what to do in 2010? Eur J Echocardiogr 2010;11:81-96.
12. Chemla D, Castelain V, Humbert M et al. New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest 2004;126:1313-7.
13. Hachulla E, Coghlan G. Eular textbook on systemic sclerosis. Hoboken, New Jersey: BMJ Group, 2013.
14. McLaughlin VV, Archer SL, Badesch DB et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension. J Am Coll Cardiol 2009;53:1573-619.
15. Hoeper MM, Bogaard HJ, Condliffe R et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013;62(25 Suppl):D42-50.
16. Hachulla E, Launay D, Le Pavec J et al. [Systemic sclerosis associated pulmonary arterial hypertension: the pitfalls]. Presse Méd 2011;40(Suppl 1):1S46-53.